Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Greimel, E; Nagele, E; Lanceley, A; Oberguggenberger, AS; Nordin, A; Kuljanic, K; Arraras, JI; Wei-Chu, C; Jensen, PT; Tomaszewski, KA; Creutzberg, CL; Galalae, R; Toelen, H; Zimmermann, K; Bjelic-Radisic, V; Costantini, A; Almont, T; Serpentini, S; Paskeviciute, Frøding, L; Vistad, I; Schmalz, C, , EORTC, Quality, of, Life, Group.
Psychometric validation of the European Organisation for Research and Treatment of Cancer-Quality of Life Questionnaire Sexual Health (EORTC QLQ-SH22).
Eur J Cancer. 2021; 154:235-245
Doi: 10.1016/j.ejca.2021.06.003
Web of Science
PubMed
FullText
FullText_MUG
- Leading authors Med Uni Graz
- Greimel Elfriede Renate
- Co-authors Med Uni Graz
- Bjelic-Radisic Vesna
- Nagele Eva Helene
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- BACKGROUND: The European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Group developed a questionnaire to assess sexual health in patients with cancer and cancer survivors. This study evaluates the psychometric properties of the questionnaire. METHODS: The 22-item EORTC sexual health questionnaire (EORTC QLQ-SH22) was administered with the EORTC QLQ-C30 to 444 patients with cancer. The hypothesised scale structure, reliability and validity were evaluated through standardised psychometric procedures. RESULTS: The cross-cultural field study showed that the majority of patients (94.7%) were able to complete the QLQ-SH22 in less than 20 min; 89% of the study participants did not need any help to fill in the questionnaire. Multi-item multi-trait scaling analysis confirmed the hypothesised scale structure with two multi-item scales (sexual satisfaction, sexual pain) and 11 single items (including five conditional items and four gender-specific items). The internal consistency yielded acceptable Cronbach's alpha coefficients (.90 for the sexual satisfaction scale, .80 for the sexual pain scale). The test-retest correlations (Pearson's r) ranged from .70 to .93 except for the scale communication with professionals (.67) and male body image (.69). The QLQ-SH22 discriminates well between subgroups of patients differing in terms of their performance and treatment status. CONCLUSION: The study supports the reliability, the content and construct validity of the QLQ-SH22. The newly developed questionnaire is clinically applicable to assess sexual health of patients with cancer at different treatment stages and during survivorship for clinical trials and for clinical practice.
- Find related publications in this database (using NLM MeSH Indexing)
- Adult - administration & dosage
- Aged - administration & dosage
- Aged, 80 and over - administration & dosage
- Cancer Survivors - psychology
- Female - administration & dosage
- Humans - administration & dosage
- Male - administration & dosage
- Middle Aged - administration & dosage
- Neoplasms - psychology
- Psychometrics - administration & dosage
- Quality of Life - administration & dosage
- Sexual Health - administration & dosage
- Surveys and Questionnaires - administration & dosage
- Young Adult - administration & dosage
- Find related publications in this database (Keywords)
- Sexual health
- Quality of life
- Cancer
- Questionnaire development
- EORTC
- Cross-cultural validation
- Psychometric properties